Back
Greek Organisation of Football Prognostics SA Vs. Akero Therapeutics Industry Stock Comparison
Buy
78
GOFPY
Greek Organisation of Football Prognostics SA
Last Price:
$11.26
Seasonality Move:
-1.92%
Buy
64
AKRO
Akero Therapeutics
Last Price:
$46.37
Seasonality Move:
17.51%
Buy
78
Greek Organisation of Football Prognostics SA (GOFPY)
is a Buy
Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?
-
The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $11.52. The Score for GOFPY is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
GOFPY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $48.97. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GOFPY Stock Price Chart
What is Greek Organisation of Football Prognostics SA's stock price today?
-
The Greek Organisation of Football Prognostics SA share price today is $11.52The current trend is moderately bullish and GOFPY is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $48.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
GOFPY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 58.73 | Buy |
| Chaikin Money Flow: | -3056 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.91 - 11.47) | Buy |
| Bollinger Bands (100): | (8.46 - 10.72) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 64.94 | Buy |
| Chaikin Money Flow: | -536219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.67 - 45.31) | Buy |
| Bollinger Bands (100): | (31.92 - 49.9) | Buy |
GOFPY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.4 | Buy |
| 20-day SMA: | 11.26 | Buy |
| 50-day SMA: | 10.56 | Buy |
| 200-day SMA: | 9.06 | Buy |
| 8-day EMA: | 11.43 | Buy |
| 20-day EMA: | 11.22 | Buy |
| 50-day EMA: | 10.62 | Buy |
| 200-day EMA: | 9.36 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.47 | Buy |
| 20-day SMA: | 42.76 | Buy |
| 50-day SMA: | 41.41 | Buy |
| 200-day SMA: | 34.81 | Buy |
| 8-day EMA: | 44.34 | Buy |
| 20-day EMA: | 42.59 | Buy |
| 50-day EMA: | 41.78 | Buy |
| 200-day EMA: | 36.47 | Buy |
Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.69 per share.
Greek Organisation of Football Prognostics SA Technical Analysis
| May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||